[1]
|
Gallily, R. and Yekhtin, Z. (2019) Avidekel Cannabis Extracts and Cannabidiol Are as Efficient as Copaxone in Suppressing EAE in SJL/J Mice. Inflammopharmacology, 27, 167-173. https://doi.org/10.1007/s10787-018-0536-3
|
[2]
|
Weiss, L., Zeira, M., Reich, S., Slavin, S., Raz, I., Mechoulam, R. and Gallily, R. (2008) Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice. Neuropharmacology, 54, 244-249. https://doi.org/10.1016/j.neuropharm.2007.06.029
|
[3]
|
Gallily, R., Yekhtin, Z. and Hanus, L.O. (2015) Overcoming the Bell-Shaped Dose- Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol. Pharmacology & Pharmacy, 6, 75-85. https://doi.org/10.4236/pp.2015.62010
|
[4]
|
Malfait, A.M., Gallily, R., Sumariwalla, P.F., Malik, A.S., Andreakos, E., Mechoulam, R. and Feldmann, M. (2000) The Nonpsychoactive Cannabis Constituent Cannabidiol Is an Oral Anti-Arthritic Therapeutic in Murine Collagen-Induced Arthritis. Proceedings of the National Academy of Sciences of the United States of America, 97, 9561-9566. https://doi.org/10.1073/pnas.160105897
|
[5]
|
Watkins, A.R. (2019) Cannabinoid Interactions with Ion Channels and Receptors. Channels (Austin), 13, 162-167. https://doi.org/10.1080/19336950.2019.1615824
|
[6]
|
McPartland, J.M., Duncan, M., Di Marzo, V. and Pertwee, R.G. (2015) Are Cannabidiol and D9-Tetrahydrocannabivarin Negative Modulators of the Endocannabinoid System? A Systematic Review. British Journal of Pharmacology, 172, 737-753. https://doi.org/10.1111/bph.12944
|
[7]
|
Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., Smith, E. and Rahman, M.M. (2008) Antibacterial Cannabinoids from Cannabis sativa: A Structure-Activity Study. Journal of Natural Products, 71, 1427-1430. https://doi.org/10.1021/np8002673
|
[8]
|
Crippa, J.A., Guimaraes, F.S., Campos, A.C. and Zuardi, A.W. (2018) Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. Frontiers in Immunology, 9, 2009. https://doi.org/10.3389/fimmu.2018.02009
|
[9]
|
Pisanti, S., Malfitano, A.M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M.C., Fiore, D., et al. (2017) Cannabidiol: State of the Art and New Challenges for Therapeutic Applications. Pharmacology & Therapeutics, 175, 133-150. https://doi.org/10.1016/j.pharmthera.2017.02.041
|
[10]
|
Sacerdote, P., Martucci, C., Vaccani, A., Bariselli, F., Panerai, A.E., Colombo, A., Parolaro, D. and Massi, P. (2005) The Nonpsychoactive Component of Marijuana Cannabidiol Modulates Chemotaxis and IL-10 and IL-12 Production of Murine Macrophages Both in Vivo and in Vitro. Journal of Neuroimmunology, 159, 97-105. https://doi.org/10.1016/j.jneuroim.2004.10.003
|
[11]
|
Haj, C.G., Sumariwalla, P.F., Hanus, L., Kogan, N.M., Yektin, Z., Mechoulam, R., Feldmann, M. and Gallily, R. (2015) HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid. Journal of Pharmacology and Experimental Therapeutics, 355, 66-75. https://doi.org/10.1124/jpet.115.226100
|
[12]
|
Ben-Shabat, S., Hanus, L.O., Katzavian, G. and Gallily, R. (2006) New Cannabidiol Derivatives: Synthesis, Binding to Cannabinoid Receptor, and Evaluation of Their Antiinflammatory Activity. Journal of Medicinal Chemistry, 49, 1113-1117. https://doi.org/10.1021/jm050709m
|
[13]
|
Steffens, S., Veillard, N.R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Karsak, M., Zimmer, A., Frossard, J.L. and Mach, F. (2005) Low Dose Oral Cannabinoid Therapy Reduces Progression of Atherosclerosis in Mice. Nature, 434, 782-786. https://doi.org/10.1038/nature03389
|
[14]
|
Juknat, A., Gao, F., Coppola, G., Vogel, Z. and Kozela, E. (2019) miRNA Expression Profiles and Molecular Networks in Resting and LPS-Activated BV-2 Microglia-Effect of Cannabinoids. PLoS ONE, 14, e0212039. https://doi.org/10.1371/journal.pone.0212039
|
[15]
|
Seimon, T.A., Nadolski, M.J., Liao, X., Magallon, J., Nguyen, M., Feric, N.T., Koschinsky, M.L., Harkewicz, R., Witztum, J.L., Tsimikas, S., et al. (2010) Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress. Cell Metabolism, 12, 467-482. https://doi.org/10.1016/j.cmet.2010.09.010
|
[16]
|
Kim, D.H., Cho, Y.M., Lee, K.H., Jeong, S.W. and Kwon, O.J. (2017) Oleate Protects Macrophages from Palmitate-Induced Apoptosis through the Downregulation of CD36 Expression. Biochemical and Biophysical Research Communications, 488, 477-482. https://doi.org/10.1016/j.bbrc.2017.05.066
|
[17]
|
Wang, Z., Liu, D., Wang, F., Liu, S., Zhao, S., Ling, E.A. and Hao, A. (2012) Saturated Fatty Acids Activate Microglia via Toll-Like Receptor 4/NF-kappaB Signalling. British Journal of Nutrition, 107, 229-241. https://doi.org/10.1017/S0007114511002868
|
[18]
|
Hidalgo-Lanussa, O., Avila-Rodriguez, M., Baez-Jurado, E., Zamudio, J., Echeverria, V., Garcia-Segura, L.M. and Barreto, G.E. (2018) Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta. Molecular Neurobiology, 55, 5462- 5477. https://doi.org/10.1007/s12035-017-0777-y
|
[19]
|
Chen, R., Gao, X., Zhang, L., Zhao, W., Zeng, L., Zhu, Y. and Fu, Z. (2018) Cannabidiol Attenuates Palmitic Acid-Induced Injury in Cultured Hepatocytes through Promoting Autophagic Flux. International Journal of Clinical and Experimental Medical Sciences, 4, 51-56. https://doi.org/10.11648/j.ijcems.20180403.15
|
[20]
|
Ryan, D., Drysdale, A.J., Lafourcade, C., Pertwee, R.G. and Platt, B. (2009) Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels. Journal of Neuroscience, 29, 2053-2063. https://doi.org/10.1523/JNEUROSCI.4212-08.2009
|